Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Milano

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Endocrine, Metabolic & Immune Disorders Drug Targets|December 13, 2017
Neuroendocrine and Metabolic Disorders in Bulimia NervosaWalter Milano, Anna Capasso
Endocrine, Metabolic & Immune Disorders Drug Targets|April 26, 2017
Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment ApproachWalter Milano, Chiara Colletti, Anna Capasso
Endocrine, Metabolic & Immune Disorders Drug Targets|November 6, 2019
Eating Disorders in Athletes: From Risk Management to TherapyWalter Milano, Luca Milano, Anna Capasso
Reviews on Recent Clinical Trials|January 20, 2009
Recent clinical aspects of eating disordersAnna Capasso, Claudio Putrella, Walter Milano
Endocrine, Metabolic & Immune Disorders Drug Targets|February 14, 2018
Changes in the Peripheral Endocannabinoid System as a Risk Factor for the Development of Eating DisordersAnna Capasso, Walter Milano, Omar Cauli
Current Clinical Pharmacology|January 20, 2009
Pharmacological profile of SSRIs and SNRIs in the treatment of eating disordersAnna Capasso, Claudio Petrella, Walter Milano
The Open Neurology Journal|July 30, 2013
Antipsychotic drugs opposite to metabolic risk: neurotransmitters, neurohormonal and pharmacogenetic mechanisms underlying with weight gain and metabolic syndromeWalter Milano, Michele De Rosa, Luca Milano, et al.
Case Reports in Medicine|June 14, 2013
Agomelatine efficacy in the night eating syndromeWalter Milano, Michele De Rosa, Luca Milano, et al.
The Journal of Pharmacy and Pharmacology|December 14, 2011
Night eating syndrome: an overviewWalter Milano, Michele De Rosa, Luca Milano, et al.
Journal of Clinical Psychopharmacology|July 16, 2010
Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gainPalmiero Monteleone, Walter Milano, Claudio Petrella, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Endocrine, Metabolic & Immune Disorders Drug Targets|December 13, 2017
Neuroendocrine and Metabolic Disorders in Bulimia NervosaWalter Milano, Anna Capasso
Endocrine, Metabolic & Immune Disorders Drug Targets|April 26, 2017
Hyperprolactinemia Induced by Antipsychotics: From Diagnosis to Treatment ApproachWalter Milano, Chiara Colletti, Anna Capasso
Endocrine, Metabolic & Immune Disorders Drug Targets|November 6, 2019
Eating Disorders in Athletes: From Risk Management to TherapyWalter Milano, Luca Milano, Anna Capasso
Reviews on Recent Clinical Trials|January 20, 2009
Recent clinical aspects of eating disordersAnna Capasso, Claudio Putrella, Walter Milano
Endocrine, Metabolic & Immune Disorders Drug Targets|February 14, 2018
Changes in the Peripheral Endocannabinoid System as a Risk Factor for the Development of Eating DisordersAnna Capasso, Walter Milano, Omar Cauli
Current Clinical Pharmacology|January 20, 2009
Pharmacological profile of SSRIs and SNRIs in the treatment of eating disordersAnna Capasso, Claudio Petrella, Walter Milano
The Open Neurology Journal|July 30, 2013
Antipsychotic drugs opposite to metabolic risk: neurotransmitters, neurohormonal and pharmacogenetic mechanisms underlying with weight gain and metabolic syndromeWalter Milano, Michele De Rosa, Luca Milano, et al.
Case Reports in Medicine|June 14, 2013
Agomelatine efficacy in the night eating syndromeWalter Milano, Michele De Rosa, Luca Milano, et al.
The Journal of Pharmacy and Pharmacology|December 14, 2011
Night eating syndrome: an overviewWalter Milano, Michele De Rosa, Luca Milano, et al.
Journal of Clinical Psychopharmacology|July 16, 2010
Endocannabinoid Pro129Thr FAAH functional polymorphism but not 1359G/A CNR1 polymorphism is associated with antipsychotic-induced weight gainPalmiero Monteleone, Walter Milano, Claudio Petrella, et al.
Pageof 3